MRI features and IDH mutational status of grade II diffuse gliomas: Impact on diagnosis and prognosis

Javier E. Villanueva-Meyer, Matthew Wood, Byung Se Choi, Marc C. Mabray, Nicholas A. Butowski, Tarik Tihan, Soonmee Cha

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

OBJECTIVE. Grade II diffuse gliomas (DGs) with isocitrate dehydrogenase (IDH) mutations are associated with better prognosis than their IDH wild-type counterparts. We sought to determine the MRI characteristics associated with IDH mutational status and ascertain whether MRI considered in combination with IDH mutational status can better predict the clinical outcomes of grade II DGs. MATERIALS AND METHODS. Preoperative MRI examinations were retrospectively studied for qualitative tumor characteristics, including location, extent, cortical involvement, margin sharpness, cystic component, mineralization or hemorrhage, and contrast enhancement. Quantitative diffusion and perfusion metrics were also assessed. Logistic regression and ROC analyses were used to evaluate the relationship between MRI features and IDH mutational status. The association between IDH mutational status, 1p19q codeletion, MRI features, extent of resection, and clinical outcomes was assessed by Kaplan-Meier and Cox proportional hazards models. RESULTS. Of 100 grade II DGs, 78 were IDH mutant and 22 were IDH wild type. IDH wild-type tumors were associated with older age, multifocality, brainstem involvement, lack of cystic change, and a lower apparent diffusion coefficient (ADC). Multivariable regression showed that age older than 45 years as well as low minimum ADC (ADCmin), mean ADC, and maximum ADC values were independently associated with IDH mutational status. Of these, an ADCmin threshold of 0.9 × 10−3 mm2/s or less provided the greatest sensitivity and specificity (91% and 76%, respectively) in defining IDH wild-type grade II DGs. Combining low ADCmin with IDH wild-type status conferred worse outcomes than did IDH wild-type status alone. CONCLUSION. IDH wild-type grade II DGs are associated with a lower ADC and poor clinical outcomes. Combining IDH mutational status and ADC may allow more accurate prediction of clinical outcomes for patients with grade II DGs.

Original languageEnglish (US)
Pages (from-to)621-628
Number of pages8
JournalAmerican Journal of Roentgenology
Volume210
Issue number3
DOIs
StatePublished - Mar 1 2018
Externally publishedYes

Fingerprint

Isocitrate Dehydrogenase
Glioma
Proportional Hazards Models

Keywords

  • Grade II diffuse gliomas
  • IDH
  • Isocitrate dehydrogenase
  • Low-grade glioma
  • MRI

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Villanueva-Meyer, J. E., Wood, M., Choi, B. S., Mabray, M. C., Butowski, N. A., Tihan, T., & Cha, S. (2018). MRI features and IDH mutational status of grade II diffuse gliomas: Impact on diagnosis and prognosis. American Journal of Roentgenology, 210(3), 621-628. https://doi.org/10.2214/AJR.17.18457

MRI features and IDH mutational status of grade II diffuse gliomas : Impact on diagnosis and prognosis. / Villanueva-Meyer, Javier E.; Wood, Matthew; Choi, Byung Se; Mabray, Marc C.; Butowski, Nicholas A.; Tihan, Tarik; Cha, Soonmee.

In: American Journal of Roentgenology, Vol. 210, No. 3, 01.03.2018, p. 621-628.

Research output: Contribution to journalArticle

Villanueva-Meyer, Javier E. ; Wood, Matthew ; Choi, Byung Se ; Mabray, Marc C. ; Butowski, Nicholas A. ; Tihan, Tarik ; Cha, Soonmee. / MRI features and IDH mutational status of grade II diffuse gliomas : Impact on diagnosis and prognosis. In: American Journal of Roentgenology. 2018 ; Vol. 210, No. 3. pp. 621-628.
@article{9001a7048a7c489c8abfd02714fb8d10,
title = "MRI features and IDH mutational status of grade II diffuse gliomas: Impact on diagnosis and prognosis",
abstract = "OBJECTIVE. Grade II diffuse gliomas (DGs) with isocitrate dehydrogenase (IDH) mutations are associated with better prognosis than their IDH wild-type counterparts. We sought to determine the MRI characteristics associated with IDH mutational status and ascertain whether MRI considered in combination with IDH mutational status can better predict the clinical outcomes of grade II DGs. MATERIALS AND METHODS. Preoperative MRI examinations were retrospectively studied for qualitative tumor characteristics, including location, extent, cortical involvement, margin sharpness, cystic component, mineralization or hemorrhage, and contrast enhancement. Quantitative diffusion and perfusion metrics were also assessed. Logistic regression and ROC analyses were used to evaluate the relationship between MRI features and IDH mutational status. The association between IDH mutational status, 1p19q codeletion, MRI features, extent of resection, and clinical outcomes was assessed by Kaplan-Meier and Cox proportional hazards models. RESULTS. Of 100 grade II DGs, 78 were IDH mutant and 22 were IDH wild type. IDH wild-type tumors were associated with older age, multifocality, brainstem involvement, lack of cystic change, and a lower apparent diffusion coefficient (ADC). Multivariable regression showed that age older than 45 years as well as low minimum ADC (ADCmin), mean ADC, and maximum ADC values were independently associated with IDH mutational status. Of these, an ADCmin threshold of 0.9 × 10−3 mm2/s or less provided the greatest sensitivity and specificity (91{\%} and 76{\%}, respectively) in defining IDH wild-type grade II DGs. Combining low ADCmin with IDH wild-type status conferred worse outcomes than did IDH wild-type status alone. CONCLUSION. IDH wild-type grade II DGs are associated with a lower ADC and poor clinical outcomes. Combining IDH mutational status and ADC may allow more accurate prediction of clinical outcomes for patients with grade II DGs.",
keywords = "Grade II diffuse gliomas, IDH, Isocitrate dehydrogenase, Low-grade glioma, MRI",
author = "Villanueva-Meyer, {Javier E.} and Matthew Wood and Choi, {Byung Se} and Mabray, {Marc C.} and Butowski, {Nicholas A.} and Tarik Tihan and Soonmee Cha",
year = "2018",
month = "3",
day = "1",
doi = "10.2214/AJR.17.18457",
language = "English (US)",
volume = "210",
pages = "621--628",
journal = "AJR. American journal of roentgenology",
issn = "0361-803X",
publisher = "American Roentgen Ray Society",
number = "3",

}

TY - JOUR

T1 - MRI features and IDH mutational status of grade II diffuse gliomas

T2 - Impact on diagnosis and prognosis

AU - Villanueva-Meyer, Javier E.

AU - Wood, Matthew

AU - Choi, Byung Se

AU - Mabray, Marc C.

AU - Butowski, Nicholas A.

AU - Tihan, Tarik

AU - Cha, Soonmee

PY - 2018/3/1

Y1 - 2018/3/1

N2 - OBJECTIVE. Grade II diffuse gliomas (DGs) with isocitrate dehydrogenase (IDH) mutations are associated with better prognosis than their IDH wild-type counterparts. We sought to determine the MRI characteristics associated with IDH mutational status and ascertain whether MRI considered in combination with IDH mutational status can better predict the clinical outcomes of grade II DGs. MATERIALS AND METHODS. Preoperative MRI examinations were retrospectively studied for qualitative tumor characteristics, including location, extent, cortical involvement, margin sharpness, cystic component, mineralization or hemorrhage, and contrast enhancement. Quantitative diffusion and perfusion metrics were also assessed. Logistic regression and ROC analyses were used to evaluate the relationship between MRI features and IDH mutational status. The association between IDH mutational status, 1p19q codeletion, MRI features, extent of resection, and clinical outcomes was assessed by Kaplan-Meier and Cox proportional hazards models. RESULTS. Of 100 grade II DGs, 78 were IDH mutant and 22 were IDH wild type. IDH wild-type tumors were associated with older age, multifocality, brainstem involvement, lack of cystic change, and a lower apparent diffusion coefficient (ADC). Multivariable regression showed that age older than 45 years as well as low minimum ADC (ADCmin), mean ADC, and maximum ADC values were independently associated with IDH mutational status. Of these, an ADCmin threshold of 0.9 × 10−3 mm2/s or less provided the greatest sensitivity and specificity (91% and 76%, respectively) in defining IDH wild-type grade II DGs. Combining low ADCmin with IDH wild-type status conferred worse outcomes than did IDH wild-type status alone. CONCLUSION. IDH wild-type grade II DGs are associated with a lower ADC and poor clinical outcomes. Combining IDH mutational status and ADC may allow more accurate prediction of clinical outcomes for patients with grade II DGs.

AB - OBJECTIVE. Grade II diffuse gliomas (DGs) with isocitrate dehydrogenase (IDH) mutations are associated with better prognosis than their IDH wild-type counterparts. We sought to determine the MRI characteristics associated with IDH mutational status and ascertain whether MRI considered in combination with IDH mutational status can better predict the clinical outcomes of grade II DGs. MATERIALS AND METHODS. Preoperative MRI examinations were retrospectively studied for qualitative tumor characteristics, including location, extent, cortical involvement, margin sharpness, cystic component, mineralization or hemorrhage, and contrast enhancement. Quantitative diffusion and perfusion metrics were also assessed. Logistic regression and ROC analyses were used to evaluate the relationship between MRI features and IDH mutational status. The association between IDH mutational status, 1p19q codeletion, MRI features, extent of resection, and clinical outcomes was assessed by Kaplan-Meier and Cox proportional hazards models. RESULTS. Of 100 grade II DGs, 78 were IDH mutant and 22 were IDH wild type. IDH wild-type tumors were associated with older age, multifocality, brainstem involvement, lack of cystic change, and a lower apparent diffusion coefficient (ADC). Multivariable regression showed that age older than 45 years as well as low minimum ADC (ADCmin), mean ADC, and maximum ADC values were independently associated with IDH mutational status. Of these, an ADCmin threshold of 0.9 × 10−3 mm2/s or less provided the greatest sensitivity and specificity (91% and 76%, respectively) in defining IDH wild-type grade II DGs. Combining low ADCmin with IDH wild-type status conferred worse outcomes than did IDH wild-type status alone. CONCLUSION. IDH wild-type grade II DGs are associated with a lower ADC and poor clinical outcomes. Combining IDH mutational status and ADC may allow more accurate prediction of clinical outcomes for patients with grade II DGs.

KW - Grade II diffuse gliomas

KW - IDH

KW - Isocitrate dehydrogenase

KW - Low-grade glioma

KW - MRI

UR - http://www.scopus.com/inward/record.url?scp=85042789328&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042789328&partnerID=8YFLogxK

U2 - 10.2214/AJR.17.18457

DO - 10.2214/AJR.17.18457

M3 - Article

C2 - 29261348

AN - SCOPUS:85042789328

VL - 210

SP - 621

EP - 628

JO - AJR. American journal of roentgenology

JF - AJR. American journal of roentgenology

SN - 0361-803X

IS - 3

ER -